Rare ovarian tumors: an update on diagnosis and treatment C Debuquoy, C Romeo, H Vanacker, I Ray-Coquard International Journal of Gynecologic Cancer 30 (6), 2020 | 15 | 2020 |
Non-pegylated liposomal doxorubicin (NPLD, Myocet®)+ carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trial C Romeo, F Joly, I Ray-Coquard, C El Kouri, A Mercier-Blas, ... Gynecologic Oncology 152 (1), 68-75, 2019 | 9 | 2019 |
Therapeutic challenges in patients with gynecologic carcinosarcomas: analysis of a multicenter national cohort study from the French prospective TMRG network C Romeo, O Le Saux, M Jacobs, F Joly, G Ferron, L Favier, JD Fumet, ... Cancers 14 (2), 354, 2022 | 5 | 2022 |
ESR1 Rearrangement as a Diagnostic and Predictive Biomarker in Uterine Tumor Resembling Ovarian Sex Cord Tumor: A Report of Four Cases M Bini, J Gantzer, A Dufresne, H Vanacker, C Romeo, T Franceschi, ... JCO precision oncology 7, e2300130, 2023 | 3 | 2023 |
Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salomé study including 469 patients. A TMRG and GINECO group study B Hanvic, F Lecuru, H Vanacker, P Pautier, F Narducci, F Cherifi, ... Gynecologic Oncology 174, 190-199, 2023 | 3 | 2023 |
EP967 Natural history of patients with BRCA-mutated high grade epithelial ovarian cancer (HGEOC) before the era of PARP inhibitors maintenance in 1st line treatment C Romeo, P Meeus, M Rodrigues, E Leblanc, A Floquet, P Pautier, ... International Journal of Gynecologic Cancer 29 (Suppl 4), 2019 | 3 | 2019 |
Current role of poly (ADP-ribose) polymerase inhibitors: which poly (ADP-ribose) polymerase inhibitor and when? H Vanacker, C Romeo, I Ray-Coquard Current Opinion in Oncology 31 (5), 394-403, 2019 | 3 | 2019 |
Poly (ADP-ribose) polymerase inhibitors in combination with anti-angiogenic agents for the treatment of advanced ovarian cancer O Le Saux, H Vanacker, F Guermazi, M Carbonnaux, C Roméo, ... Future Oncology 17 (18), 2291-2304, 2021 | 2 | 2021 |
Real-World Data on Newly Diagnosed BRCA-Mutated High-Grade Epithelial Ovarian Cancers: The French National Multicenter ESME Database M Bini, S Quesada, P Meeus, M Rodrigues, E Leblanc, A Floquet, ... Cancers 14 (16), 4040, 2022 | 1 | 2022 |
Gynecological carcinosarcomas: Overview and future perspectives L Collet, AMG López, C Romeo, P Méeus, N Chopin, L Rossi, E Rowinski, ... Bulletin du Cancer, 2023 | | 2023 |
Pembrolizumab and Chemotherapy in Cervical Cancer: A New Standard of Care? C Lebreton, O Le Saux, B Mery, M Bini, C Roméo, I Ray-Coquard 1, 2022 | | 2022 |
Personalized medicine for advanced pancreas cancer: access to treatment according to molecular profile C Romeo, P Cassier, A De Fouchardière, D Pissaloux, V Attignon, ... Annals of Oncology 27, vi225, 2016 | | 2016 |